Literature DB >> 21691193

Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements.

Raj Vuppalanchi1, Ravi Juluri, Lauren N Bell, Marwan Ghabril, Lisa Kamendulis, James E Klaunig, Romil Saxena, David Agarwal, Matthew S Johnson, Naga Chalasani.   

Abstract

INTRODUCTION: Oxidative stress plays an important role in the pathogenesis of many liver diseases. Investigators often measure markers of oxidative stress in peripheral veins as a reflection of hepatic oxidative stress as it is not always feasible to measure oxidative stress in liver tissue. However, it is unknown whether markers of oxidative stress measured from peripheral sites accurately reflect hepatic tissue oxidative stress. The aim of this study is to examine the relationship of oxidative stress marker among hepatic tissue, hepatic and peripheral veins and urine.
METHODS: Malondialdehyde (MDA), a marker of oxidative stress was measured in hepatic vein, peripheral vein and urine samples from 26 consecutive patients undergoing transjugular liver procedures. In 19 patients undergoing liver biopsies, we measured MDA by immunohistochemical staining of paraffin-embedded liver tissue.
RESULTS: Peripheral venous MDA levels showed significant correlation with hepatic venous MDA levels (r = 0.62, P = 0.02), but they did not correlate with hepatic tissue MDA content (r = 0.22, P = 0.4). Hepatic venous MDA levels did not correlate with hepatic tissue MDA content (r = -0.01, P = 0.9). Subgroup analysis of patients without portal hypertension showed a positive correlation between hepatic venous and hepatic tissue MDA levels, but this was not statistically significant (r = 0.45, P = 0.22). Urinary MDA did not correlate with MDA from any other sampling location.
CONCLUSION: Oxidative stress measured from the peripheral venous samples is poorly reflective of hepatic tissue oxidative stress. Hepatic venous sampling might be suitable for assessing hepatic tissue oxidative stress in patients without portal hypertension, but a larger study is needed to examine this possibility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691193      PMCID: PMC3644215          DOI: 10.1097/MAJ.0b013e31821d9905

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  22 in total

Review 1.  Oxidative stress.

Authors:  Emmanuel C Opara
Journal:  Dis Mon       Date:  2006-05       Impact factor: 3.800

Review 2.  The pathophysiological significance of lipid peroxidation in oxidative cell injury.

Authors:  D L Tribble; T Y Aw; D P Jones
Journal:  Hepatology       Date:  1987 Mar-Apr       Impact factor: 17.425

3.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

4.  Methyl malondialdehyde is not suitable as an internal standard for malondialdehyde detection in urine after derivatisation with 2,4-dinitrophenylhydrazine.

Authors:  Olga Korchazhkina; Ying Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-07-05       Impact factor: 3.205

5.  Effect of vitamin E on reoxygenation injury experienced by isolated rat hepatocytes.

Authors:  P Caraceni; T Yao; S Degli Esposti; A Gasbarrini; B T Bowie; M Zern; A B Borle; D H Van Thiel
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

6.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

7.  Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.

Authors:  Naga Chalasani; Mark A Deeg; David W Crabb
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

Review 8.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

Authors:  A Negre-Salvayre; C Coatrieux; C Ingueneau; R Salvayre
Journal:  Br J Pharmacol       Date:  2007-07-23       Impact factor: 8.739

9.  Oxidative stress tests: overview on reliability and use. Part II.

Authors:  B Palmieri; V Sblendorio
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Nov-Dec       Impact factor: 3.507

10.  Oxidant stress is a significant feature of primary biliary cirrhosis.

Authors:  Ali Aboutwerat; Philip W Pemberton; Alexander Smith; Peter C Burrows; Raymond F T McMahon; Sanjiv K Jain; Thomas W Warnes
Journal:  Biochim Biophys Acta       Date:  2003-03-20
View more
  8 in total

1.  Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in Rats.

Authors:  Maysa Ahmed Mobasher; Hala Galal El-Tantawi; Karim Samy El-Said
Journal:  Rep Biochem Mol Biol       Date:  2020-04

2.  Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.

Authors:  Bin Zhang; Cheng-Gang Zhang; Quan-Bo Zhou; Wei Chen; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

3.  Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of 'sterile inflammation' in patients with alcoholic cirrhosis and hepatorenal syndrome type II.

Authors:  Vanja P Nickovic; Dijana Miric; Bojana Kisic; Hristina Kocic; Marko Stojanovic; Salvatore Buttice; Gordana Kocic
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 4.  Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?

Authors:  O S Ademowo; H K I Dias; D G A Burton; H R Griffiths
Journal:  Biogerontology       Date:  2017-05-24       Impact factor: 4.277

5.  Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients.

Authors:  Abdulrahman Hamdan Almaeen; Abdulrahman Abdulwahab Alduraywish; Maysa Ahmed Mobasher; Omar I M Almadhi; Hanan M Nafeh; Tarek Hassan El-Metwally
Journal:  Arch Med Sci       Date:  2020-01-03       Impact factor: 3.318

6.  Contribution of environment and genetics to pancreatic cancer susceptibility.

Authors:  Barbara A Hocevar; Lisa M Kamendulis; Xinzhu Pu; Susan M Perkins; Zheng-Yu Wang; Erica L Johnston; John M DeWitt; Lang Li; Patrick J Loehrer; James E Klaunig; E Gabriela Chiorean
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

7.  The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.

Authors:  Yahya A Al-Zahrani; Sameer E Al-Harthi; Lateef M Khan; Hani M El-Bassossy; Sherif M Edris; Mai A Alim A Sattar
Journal:  Saudi Pharm J       Date:  2015-01-07       Impact factor: 4.330

8.  Active chemical fractions of stem bark extract of Khaya grandifoliola C.DC and Entada africana Guill. et Perr. synergistically protect primary rat hepatocytes against paracetamol-induced damage.

Authors:  Frédéric Nico Njayou; Arnaud Fondjo Kouam; Brice Fredy Nemg Simo; Angèle Nkouatchoua Tchana; Paul Fewou Moundipa
Journal:  BMC Complement Altern Med       Date:  2016-07-07       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.